Literature DB >> 7917693

Unsuspected coronary artery disease revealed by administration of nebulised salbutamol.

H E Montgomery1, J Gill, C W Pumphrey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917693      PMCID: PMC1025484          DOI: 10.1136/hrt.72.2.181

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  5 in total

1.  The effect of maximal doses of formoterol and salbutamol from a metered dose inhaler on pulse rates, ECG, and serum potassium concentrations.

Authors:  F P Maesen; R Costongs; J J Smeets; P J Brombacher; P G Zweers
Journal:  Chest       Date:  1991-06       Impact factor: 9.410

2.  Effects of beta 2-adrenoceptor stimulation on exercise-induced myocardial ischemia.

Authors:  A Gaspardone; F Crea; J C Kaski; A Maseri
Journal:  Am J Cardiol       Date:  1991-07-01       Impact factor: 2.778

3.  Salbutamol nebuliser and precipitation of critical cardiac ischaemia.

Authors:  C L Shovlin; F W Tam
Journal:  Lancet       Date:  1990-11-17       Impact factor: 79.321

4.  Nebulised salbutamol and angina.

Authors:  E Neville; P A Corris; J Vivian; S Nariman; G J Gibson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-18

5.  The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation.

Authors:  A Flatt; J Crane; G Purdie; T Kwong; R Beasley; C Burgess
Journal:  Postgrad Med J       Date:  1990-02       Impact factor: 2.401

  5 in total
  1 in total

Review 1.  Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing.

Authors:  Preeti Gupta; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.